Related Experiment Video
Updated: Jun 2, 2026

A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood
Published on: April 28, 2016
Dietary bioactive compounds modulating satiety and appetite: mechanisms of action
Gema Casado-Hidalgo1, Marián Pueyo-Arias2, Katherine Gil-Cardoso3
1Department of Pharmacy, Faculty of Health Sciences, Universidad San Jorge, Villanueva de Gállego (Zaragoza), 50830, Spain.
Abstract:
Obesity and overweight represent critical public health problems worldwide, driving the search for effective strategies for their prevention and treatment. Modulating appetite and satiety through natural compounds present in the diet emerges as a promising approach to controlling energy intake and improving metabolic balance. This article reviews the molecular and physiological mechanisms involved in appetite regulation, including the function of gastrointestinal hormones (GLP-1, CCK, PYY, ghrelin), the role of the hypothalamus, and the influence of microbial metabolites such as short-chain fatty acids (SCFAs). Different groups of compounds such as fibres, proteins, lipids, polyphenols, saponins, and alkaloids are analyzed in relation to their capacity to modulate both orexigenic (ghrelin) and anorexigenic signals (GLP-1, CCK, PYY), as well as their broader effects on neuroendocrine and metabolic pathways. Despite the growing body of preclinical evidence, results in humans are still limited and, at times, inconsistent, underscoring the need for long-term controlled studies to clarify their mechanisms and clinical potential. This review provides a comprehensive overview of the pathways through which dietary bioactive compounds can contribute to appetite regulation, providing a scientific basis for the development of nutritional interventions aimed at combating obesity and related metabolic disorders.
Related Concept Videos
Regulation of Food Intake
Hormonal Regulation
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Bioavailability: Influencing Factors
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...

